Bupropion-SR for Smoking Reduction and Cessation in Alcohol-Dependent Outpatients: A Naturalistic, Open-Label Study

E-ISSN： 2212-3938|9|2|123-129

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.9, Iss.2, 2014-01, pp. : 123-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bupropion-SR for Smoking Cessation in Early Recovery from Alcohol Dependence: A Placebo-Controlled, Double-Blind Pilot Study

By Karam-Hage Maher Strobbe Stephen Robinson Jason D. Brower Kirk J.

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 6, 2011-11 ,pp. : 487-490

Informa Healthcare

Access to resources Recommend Favorite

Bupropion SR for smoking cessation

By West Robert

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 533-540

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Levetiracetam on Alcohol Consumption in Alcohol-Dependent Subjects: An Open Label Study

By Sarid-Segal Ofra Piechniczek-Buczek Joanna Knapp Clifford Afshar Maryam Devine Eric Sickles Laurie Uwodukunda Emma Richambault Courtney Koplow Jillian Ciraulo Domenic

The American Journal of Drug and Alcohol Abuse, Vol. 34, Iss. 4, 2008-07 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients

By Ersoy Mehmet A. Noyan Aysin M. Elbi Hayriye

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 113-120

Adis International

Access to resources Recommend Favorite

Long-Term Assessment of Topiramate for Epilepsy: An Open-Label, Single-Arm, Multicentre, Prospective Study in a Naturalistic Setting

By Hufnagel Andreas

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 779-790

Adis International

Access to resources Recommend Favorite